Literature DB >> 32144208

Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes.

Mineko Terao1, Enrico Garattini1, Maria João Romão2, Silke Leimkühler3.   

Abstract

Aldehyde oxidases (AOXs) are a small group of enzymes belonging to the larger family of molybdo-flavoenzymes, along with the well-characterized xanthine oxidoreductase. The two major types of reactions that are catalyzed by AOXs are the hydroxylation of heterocycles and the oxidation of aldehydes to their corresponding carboxylic acids. Different animal species have different complements of AOX genes. The two extremes are represented in humans and rodents; whereas the human genome contains a single active gene (AOX1), those of rodents, such as mice, are endowed with four genes (Aox1-4), clustering on the same chromosome, each encoding a functionally distinct AOX enzyme. It still remains enigmatic why some species have numerous AOX enzymes, whereas others harbor only one functional enzyme. At present, little is known about the physiological relevance of AOX enzymes in humans and their additional forms in other mammals. These enzymes are expressed in the liver and play an important role in the metabolisms of drugs and other xenobiotics. In this review, we discuss the expression, tissue-specific roles, and substrate specificities of the different mammalian AOX enzymes and highlight insights into their physiological roles.
© 2020 Terao et al.

Entities:  

Keywords:  2Fe-2S cluster; aldehyde oxidase (AOX); drug metabolism; enzyme evolution; flavin adenine dinucleotide (FAD); flavoprotein; iron-sulfur protein; metal-containing enzyme; metalloenzyme; molybdenum; molybdenum cofactor (Moco); molybdo-flavoenzyme; mouse; oxidase; oxygen radicals; xenobiotic

Mesh:

Substances:

Year:  2020        PMID: 32144208      PMCID: PMC7170512          DOI: 10.1074/jbc.REV119.007741

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  91 in total

1.  The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition.

Authors:  Ken Okamoto; Koji Matsumoto; Russ Hille; Bryan T Eger; Emil F Pai; Takeshi Nishino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

2.  The impact of single nucleotide polymorphisms on human aldehyde oxidase.

Authors:  Tobias Hartmann; Mineko Terao; Enrico Garattini; Christian Teutloff; Joshua F Alfaro; Jeffrey P Jones; Silke Leimkühler
Journal:  Drug Metab Dispos       Date:  2012-01-25       Impact factor: 3.922

3.  Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin.

Authors:  Osamu Ueda; Kazumi Sugihara; Shigeru Ohta; Shigeyuki Kitamura
Journal:  Drug Metab Dispos       Date:  2005-06-02       Impact factor: 3.922

4.  Characterization and crystallization of mouse aldehyde oxidase 3: from mouse liver to Escherichia coli heterologous protein expression.

Authors:  Martin Mahro; Catarina Coelho; José Trincão; David Rodrigues; Mineko Terao; Enrico Garattini; Miguel Saggu; Friedhelm Lendzian; Peter Hildebrandt; Maria João Romão; Silke Leimkühler
Journal:  Drug Metab Dispos       Date:  2011-06-24       Impact factor: 3.922

5.  Avian and canine aldehyde oxidases. Novel insights into the biology and evolution of molybdo-flavoenzymes.

Authors:  Mineko Terao; Mami Kurosaki; Maria Monica Barzago; Emanuela Varasano; Andrea Boldetti; Antonio Bastone; Maddalena Fratelli; Enrico Garattini
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

Review 6.  Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.

Authors:  Shigeyuki Kitamura; Kazumi Sugihara
Journal:  Xenobiotica       Date:  2013-12-13       Impact factor: 1.908

7.  Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations.

Authors:  K Tatsumi; S Kitamura; N Narai
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

8.  Reduction of tertiary amine N-oxides by liver preparations: function of aldehyde oxidase as a major N-oxide reductase.

Authors:  S Kitamura; K Tatsumi
Journal:  Biochem Biophys Res Commun       Date:  1984-06-29       Impact factor: 3.575

9.  Optimization of the Expression of Human Aldehyde Oxidase for Investigations of Single-Nucleotide Polymorphisms.

Authors:  Alessandro Foti; Tobias Hartmann; Catarina Coelho; Teresa Santos-Silva; Maria João Romão; Silke Leimkühler
Journal:  Drug Metab Dispos       Date:  2016-02-03       Impact factor: 3.922

10.  Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1.

Authors:  Silvia Schumann; Mineko Terao; Enrico Garattini; Miguel Saggu; Friedhelm Lendzian; Peter Hildebrandt; Silke Leimkühler
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

View more
  8 in total

1.  Deletion of Mocos Induces Xanthinuria with Obstructive Nephropathy and Major Metabolic Disorders in Mice.

Authors:  Delphine Sedda; Claire Mackowiak; Julie Pailloux; Elodie Culerier; Ana Dudas; Pauline Rontani; Nicolas Erard; Antoine Lefevre; Sylvie Mavel; Patrick Emond; Frederic Foucher; Marc Le Bert; Valerie F J Quesniaux; Michael J Mihatsch; Bernhard Ryffel; Madeleine Erard-Garcia
Journal:  Kidney360       Date:  2021-09-17

Review 2.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

Review 3.  COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?

Authors:  Renata Novak Kujundžić
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

4.  Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey.

Authors:  Armina Abbasi; Carolyn A Joswig-Jones; Jeffrey P Jones
Journal:  Drug Metab Dispos       Date:  2020-10-05       Impact factor: 3.922

5.  Aldehyde Oxidase Contributes to All-Trans-Retinoic Acid Biosynthesis in Human Liver.

Authors:  Guo Zhong; Chris J Seaman; Erickson M Paragas; Huaqing Xi; Karla-Luise Herpoldt; Neil P King; Jeffrey P Jones; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2020-12-18       Impact factor: 3.922

Review 6.  Molybdenum Enzymes and How They Support Virulence in Pathogenic Bacteria.

Authors:  Qifeng Zhong; Bostjan Kobe; Ulrike Kappler
Journal:  Front Microbiol       Date:  2020-12-11       Impact factor: 5.640

Review 7.  Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer.

Authors:  Renata Novak Kujundžić; Marin Prpić; Nikola Đaković; Nina Dabelić; Marko Tomljanović; Anamarija Mojzeš; Ana Fröbe; Koraljka Gall Trošelj
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

8.  Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.

Authors:  Laura Goracci; Jenny Desantis; Aurora Valeri; Beatrice Castellani; Michela Eleuteri; Gabriele Cruciani
Journal:  J Med Chem       Date:  2020-10-07       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.